[
  {
    "ts": null,
    "headline": "Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug",
    "summary": "The CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.",
    "url": "https://finnhub.io/api/news?id=417b3e3da6a566182ab942f592659bed9e208ba861c847d6743357d920bd0d4b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741032000,
      "headline": "Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug",
      "id": 133186698,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.",
      "url": "https://finnhub.io/api/news?id=417b3e3da6a566182ab942f592659bed9e208ba861c847d6743357d920bd0d4b"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2cc9f045221c4a81c2babd90f21b60a082536b11f9fff90a7003594d7255cc09",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741020120,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
      "id": 132986271,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2cc9f045221c4a81c2babd90f21b60a082536b11f9fff90a7003594d7255cc09"
    }
  },
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN",
    "summary": "NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc.  . Such investors are advised to contact Danielle...",
    "url": "https://finnhub.io/api/news?id=8ef25b684910a7e07216b908c7568d961c179a7ac3ac0724bcffdc5509f86bf1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741007765,
      "headline": "Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN",
      "id": 132955287,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc.  . Such investors are advised to contact Danielle...",
      "url": "https://finnhub.io/api/news?id=8ef25b684910a7e07216b908c7568d961c179a7ac3ac0724bcffdc5509f86bf1"
    }
  },
  {
    "ts": null,
    "headline": "Shareholders of Regeneron Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - REGN",
    "summary": "NEW YORK, March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=a75bad2d89c6addcf52480b3388bcaab984b372ce200d14e2a84637b4cc8ed86",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740980781,
      "headline": "Shareholders of Regeneron Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - REGN",
      "id": 132950607,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=a75bad2d89c6addcf52480b3388bcaab984b372ce200d14e2a84637b4cc8ed86"
    }
  }
]